252 related articles for article (PubMed ID: 30462762)
1. Interactions between Terpinen-4-ol and Nystatin on biofilm of Candida albicans and Candida tropicalis.
Tonon CC; Francisconi RS; Bordini EAF; Huacho PMM; Sardi JCO; Spolidorio DMP
Braz Dent J; 2018; 29(4):359-367. PubMed ID: 30462762
[TBL] [Abstract][Full Text] [Related]
2. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
3. Terpinen-4-ol and nystatin co-loaded precursor of liquid crystalline system for topical treatment of oral candidiasis.
Francisconi RS; Maquera-Huacho PM; Tonon CC; Calixto GMF; de Cássia Orlandi Sardi J; Chorilli M; Spolidorio DMP
Sci Rep; 2020 Jul; 10(1):12984. PubMed ID: 32737401
[TBL] [Abstract][Full Text] [Related]
4. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
[TBL] [Abstract][Full Text] [Related]
5. Antibiofilm efficacy of tea tree oil and of its main component terpinen-4-ol against Candida albicans.
Francisconi RS; Huacho PMM; Tonon CC; Bordini EAF; Correia MF; Sardi JCO; Spolidorio DMP
Braz Oral Res; 2020; 34():e050. PubMed ID: 32578760
[TBL] [Abstract][Full Text] [Related]
6. Terpinen-4-ol inhibits the growth of
Brilhante RS; Pereira VS; Oliveira JS; Rodrigues AM; de Camargo ZP; Pereira-Neto WA; Nascimento NR; Castelo-Branco DS; Cordeiro RA; Sidrim JJ; Rocha MF
Future Microbiol; 2019 Sep; 14():1221-1233. PubMed ID: 31625442
[No Abstract] [Full Text] [Related]
7. In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.
Mondello F; De Bernardis F; Girolamo A; Cassone A; Salvatore G
BMC Infect Dis; 2006 Nov; 6():158. PubMed ID: 17083732
[TBL] [Abstract][Full Text] [Related]
8. Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
Anil S; Hashem M; Vellappally S; Patil S; Bandara HM; Samaranayake LP
Mycopathologia; 2014 Oct; 178(3-4):207-15. PubMed ID: 25142726
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study.
de Castro RD; de Souza TM; Bezerra LM; Ferreira GL; Costa EM; Cavalcanti AL
BMC Complement Altern Med; 2015 Nov; 15():417. PubMed ID: 26601661
[TBL] [Abstract][Full Text] [Related]
10. Brief exposure to antimycotics reduces the extracellular phospholipase activity of Candida albicans and Candida tropicalis.
Anil S; Samaranayake LP
Chemotherapy; 2003 Sep; 49(5):243-7. PubMed ID: 14504435
[TBL] [Abstract][Full Text] [Related]
11. Stability and efficacy of combined nystatin and chlorhexidine against suspensions and biofilms of Candida albicans.
Scheibler E; da Silva RM; Leite CE; Campos MM; Figueiredo MA; Salum FG; Cherubini K
Arch Oral Biol; 2018 May; 89():70-76. PubMed ID: 29477025
[TBL] [Abstract][Full Text] [Related]
12. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
13. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole.
Pemmaraju SC; Pruthi PA; Prasad R; Pruthi V
Indian J Exp Biol; 2013 Nov; 51(11):1032-7. PubMed ID: 24416942
[TBL] [Abstract][Full Text] [Related]
14. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
[TBL] [Abstract][Full Text] [Related]
15. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
Wei GX; Xu X; Wu CD
Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
[TBL] [Abstract][Full Text] [Related]
16. Effect of antimicrobial agents incorporated into resilient denture relines on the Candida albicans biofilm.
Bueno MG; Urban VM; Barbério GS; da Silva WJ; Porto VC; Pinto L; Neppelenbroek KH
Oral Dis; 2015 Jan; 21(1):57-65. PubMed ID: 24219354
[TBL] [Abstract][Full Text] [Related]
17. Use of alcohol vinegar in the inhibition of Candida spp. and its effect on the physical properties of acrylic resins.
de Castro RD; Mota AC; de Oliveira Lima E; Batista AU; de Araújo Oliveira J; Cavalcanti AL
BMC Oral Health; 2015 Apr; 15():52. PubMed ID: 25928798
[TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms.
Monteiro DR; Silva S; Negri M; Gorup LF; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Mycoses; 2013 Nov; 56(6):672-80. PubMed ID: 23773119
[TBL] [Abstract][Full Text] [Related]
19. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
Harrison JJ; Turner RJ; Ceri H
FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429
[TBL] [Abstract][Full Text] [Related]
20. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection.
Anil S; Ellepola AN; Samaranayake LP
Mycopathologia; 2002; 153(4):179-85. PubMed ID: 12014477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
